Ajna Biosciences CEO Joel Stanley discusses the differences between botanical drugs and botanically-derived drugs.Pharmaceutical Executive spoke with Ajna Biosciences founder and CEO Joel Stanley about the current regulatory landscape surrounding cannabis, hemp, and other medications from botanicals. As he discusses, this is an area where only a few medications have made it through FDA’s approval […]
